Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New data on inflammation in multiple sclerosis using PET-MRI

Published on: 20/10/2021 Reading time: 1 min
image SLA
Retour à la recherche

Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of magnetic resonance imaging (MRI) and positron emission tomography (PET).

Using PET-MRI, Prof. Stankoff's team has just published in the journal Radiology the results of a study of 97 MS patients and 44 healthy controls showing abnormalities (increased volume and inflammation) in the choroid plexuses of the patients. The choroid plexuses are structures located in the cerebral ventricles responsible for the production of cerebrospinal fluid, and act as a barrier between the nervous system and the immune system.

These choroidal plexus abnormalities were correlated with brain inflammation, indicating disease activity. These results open a new avenue for the application of imaging of this structure as a marker of the immune response in the brain and point to the choroid plexus as an important player in the pathophysiology of the disease.

cerveau
The choroïd plexuses (circled in red) of MS patients with a remitting form are larger (on the right) than healthy controls’ (on the left)

Work by the same team published in the journal Neurology, shows activation of innate immune cells associated with white matter micro-lesions in MS patients with worsening disability, and that this immune activation follows a gradient centered around the cerebral ventricles, which contain cerebrospinal fluid.

These results obtained thanks to the combination of PET targeting innate immune cells and MRI confirm the existence of a correlation between the activation of these cells around the ventricles, privileged areas of MS lesions in contact with cerebrospinal fluid (CSF), and the worsening of the disability in patients. This suggests that molecules contained in the CSF could worsen the inflammation present in the white matter of patients and thus promote a deleterious evolution of the disease, making these molecules candidates for future research into treatments.

image
Activated innate immune cells in a patient with MS using PET-scan around ventricles.

Sources

https://pubmed.ncbi.nlm.nih.gov/33737372/
Poirion E, Tonietto M, Lejeune FX, Ricigliano VAG, Boudot de la Motte M, Benoit C, Bera G, Kuhnast B, Bottlaender M, Bodini B, Stankoff B. Neurology. 2021 Apr 6;96(14):e1865-e1875.
https://pubmed.ncbi.nlm.nih.gov/34254858/
Ricigliano VAG, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, Bottlaender M, Gervais P, Louapre C, Bodini B, Stankoff B. Radiology. 2021 Oct;301(1):166-177.
https://pubmed.ncbi.nlm.nih.gov/34545219/
Bodini B, Tonietto M, Airas L, Stankoff B. Nat Rev Neurol. 2021 Sep 20.

Our news on the subject

Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
See all our news